Matthew C. Flanigan
Analyst · Herb Hardt with Monness, Crespi, Hardt
Thanks, Dave, and good morning, everyone. Operating cash flow grew to $116 million during the third quarter, an increase of 22% over the same quarter last year. Working capital contributed $21 million to operating cash in the quarter and consistent with our normal, seasonal patterns, should be a significant source of cash in the fourth quarter as well. Optimizing returns on capital employed continues to be a major focus for our operations. We ended the third quarter with working capital at 12.3% of annualized sales, which is well below our 15% target. For the full year, we expect to generate over $350 million of operating cash, again, comfortably exceeding the amount required to fund capital expenditures and dividends. In August, we increased the quarterly dividend by 3.4% to $0.30 per share. And 2013, therefore, marks our 42nd consecutive annual dividend increase at a compound annual growth rate of 13%. At yesterday's closing price of $29.67, the current yield is 4% on our stock, which is one of the highest among all of the S&P 500 dividend aristocrats. During calendar 2013, dividends should require about $125 million of cash, which is lower than a typical year, since the dividend, normally paid in January of 2013, was accelerated into December last year in anticipations of higher individual tax rates. We expect capital expenditures in 2013 to be approximately $85 million. Our depreciation and amortization expense this year should total around $120 million. With current capacity utilization rates still relatively low, our need to invest in additional productive capacity is limited. We continue to make investments for maintenance, efficiency improvement, and growth in businesses and product lines where sales are strong. As volumes improve, we expect capital expenditure levels to increase, but longer term, they will likely remain at or below total depreciation and amortization expense. As a reminder, our incentive plans emphasize returns on capital, which include net fixed assets and working capital. This emphasis, we believe, helps ensure that we are efficiently utilizing our asset base and investing capital dollars where the highest return potential exists. Returns should continue to improve as we expand EBIT margins, while controlling invested capital in this way. In other uses of cash, we repurchased 1.1 million shares of our stock in the third quarter. Year-to-date through September, we have repurchased 3.9 million shares and issued 3.1 million. Approximately 2/3 of the issued shares were employee stock option exercises earlier in the year in response to higher stock prices. Consistent with our stated priorities for the use of excess cash flow, we will prudently buy back our stock, bearing in mind our level of cash generation, other potential opportunities to strategically grow the company and the overall outlook for the general economy. We have a standing authorization from the board to repurchase up to 10 million shares each year, but have established no specific repurchase commitment or timetable. As of today, we have approximately 6 million shares still available under this year's authorization. We recognize that our financial base remains very strong, and this gives us considerable flexibility when making investment decisions. We ended the quarter with net debt to net capital of 27.9%, which is well below the conservative end of our long-term targeted range of 30% to 40%. As we stated in yesterday's press release, we now expect full year sales of approximately $3.75 billion, which is 1% growth versus 2012. Our prior guidance range was $3.75 billion to $3.85 billion. Given this expected level of sales, we anticipate 2013 earnings of $1.61 to $1.66 per share, including $0.05 per share from discontinued operations and 6% -- $0.06 per share from the third quarter unusual acquisition-related benefit that Dave mentioned earlier. Adjusting for those, earnings from continuing operations are expected to be between $1.50 and $1.55 per share. And this implies a fourth quarter EPS guidance range of $0.31 to $0.36 on sales of approximately $900 million. Our prior range for full-year continuing operations was $1.50 to $1.65 per share. And as a reminder, we earned $1.47 of adjusted EPS from continuing operations in 2012. Now I'll turn the call over to Karl who will provide some additional segment comments.